As compared to current standard FIB-4, machine learning outperforms detection of significant fibrosis in patients with biopsy proven metabolic dysfunction-associated steatotic liver disease by 10 times higher odds of fibrosis detection, 28% reduction of unnecessary referrals and 78% prevention of missed referrals.



Source link